Literature DB >> 8660133

Venlafaxine in obsessive-compulsive disorder.

J A Yaryura-Tobias, F A Neziroglu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8660133     DOI： 10.1001/archpsyc.1996.01830070103016

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  7 in total

Review 1.  A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.

Authors:  Dan J Stein; Nastassja Koen; Naomi Fineberg; Leonardo F Fontenelle; Hisato Matsunaga; David Osser; H Blair Simpson
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

Review 2.  A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors:  L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

3.  SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder?

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2011-06

4.  Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms.

Authors:  Filip C W Van Nieuwerburgh; Damiaan A J P Denys; Herman G M Westenberg; Dieter L D Deforce
Journal:  Int J Psychiatry Clin Pract       Date:  2009-06-01       Impact factor: 1.812

Review 5.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

6.  Psychotherapy and medication management strategies for obsessive-compulsive disorder.

Authors:  Kelda H Walsh; Christopher J McDougle
Journal:  Neuropsychiatr Dis Treat       Date:  2011-08-23       Impact factor: 2.570

7.  Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Brian P Brennan; Lorrin Koran; Carol A Mathews; Gerald Nestadt; Michele Pato; Katharine A Phillips; Carolyn I Rodriguez; H Blair Simpson; Petros Skapinakis; Dan J Stein; Eric A Storch
Journal:  Psychiatry Res       Date:  2021-03-04       Impact factor: 11.225
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.